363 related articles for article (PubMed ID: 19734199)
21. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
22. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
[TBL] [Abstract][Full Text] [Related]
23. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
24. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
25. Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter.
Liu XH; Wu Y; Yao S; Levine AC; Kirschenbaum A; Collier L; Bauman WA; Cardozo CP
J Biol Chem; 2013 Jun; 288(25):17990-8. PubMed ID: 23649620
[TBL] [Abstract][Full Text] [Related]
26. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
27. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.
Shimizu T; Kagawa T; Inoue T; Nonaka A; Takada S; Aburatani H; Taga T
Mol Cell Biol; 2008 Dec; 28(24):7427-41. PubMed ID: 18852283
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
29. Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription.
Rashid S; Pilecka I; Torun A; Olchowik M; Bielinska B; Miaczynska M
J Biol Chem; 2009 Jul; 284(27):18115-28. PubMed ID: 19433865
[TBL] [Abstract][Full Text] [Related]
30. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
31. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
32. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
33. Wnt activation and alternative promoter repression of LEF1 in colon cancer.
Li TW; Ting JH; Yokoyama NN; Bernstein A; van de Wetering M; Waterman ML
Mol Cell Biol; 2006 Jul; 26(14):5284-99. PubMed ID: 16809766
[TBL] [Abstract][Full Text] [Related]
34. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.
Li N; Lee K; Xi Y; Zhu B; Gary BD; Ramírez-Alcántara V; Gurpinar E; Canzoneri JC; Fajardo A; Sigler S; Piazza JT; Chen X; Andrews J; Thomas M; Lu W; Li Y; Laan DJ; Moyer MP; Russo S; Eberhardt BT; Yet L; Keeton AB; Grizzle WE; Piazza GA
Oncogene; 2015 Mar; 34(12):1499-509. PubMed ID: 24704829
[TBL] [Abstract][Full Text] [Related]
36. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
[TBL] [Abstract][Full Text] [Related]
37. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
38. The role of CDX2 in Caco-2 cell differentiation.
Natoli M; Christensen J; El-Gebali S; Felsani A; Anderle P
Eur J Pharm Biopharm; 2013 Sep; 85(1):20-5. PubMed ID: 23958315
[TBL] [Abstract][Full Text] [Related]
39. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
Gross I; Lhermitte B; Domon-Dell C; Duluc I; Martin E; Gaiddon C; Kedinger M; Freund JN
Oncogene; 2005 Dec; 24(54):7955-63. PubMed ID: 16027724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
